Bioarctic Ab Stock Current Liabilities
| BIOA-B Stock | SEK 187.50 6.90 3.55% |
BioArctic AB fundamentals help investors to digest information that contributes to BioArctic's financial success or failures. It also enables traders to predict the movement of BioArctic Stock. The fundamental analysis module provides a way to measure BioArctic's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to BioArctic stock.
BioArctic |
BioArctic AB Company Current Liabilities Analysis
BioArctic's Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
| Competition |
In accordance with the recently published financial statements, BioArctic AB has a Current Liabilities of 0.0. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The current liabilities for all Sweden stocks is 100.0% higher than that of the company.
BioArctic Current Liabilities Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BioArctic's direct or indirect competition against its Current Liabilities to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of BioArctic could also be used in its relative valuation, which is a method of valuing BioArctic by comparing valuation metrics of similar companies.BioArctic is currently under evaluation in current liabilities category among its peers.
BioArctic Fundamentals
| Return On Equity | -0.0142 | |||
| Return On Asset | -0.0055 | |||
| Profit Margin | (0.05) % | |||
| Operating Margin | (0.03) % | |||
| Current Valuation | 26.19 B | |||
| Shares Outstanding | 73.73 M | |||
| Shares Owned By Insiders | 48.40 % | |||
| Shares Owned By Institutions | 30.39 % | |||
| Price To Earning | 12.95 X | |||
| Price To Book | 32.29 X | |||
| Price To Sales | 111.27 X | |||
| Revenue | 23.15 M | |||
| Gross Profit | 155.53 M | |||
| EBITDA | (126.63 M) | |||
| Net Income | (119.79 M) | |||
| Cash And Equivalents | 848.4 M | |||
| Cash Per Share | 13.84 X | |||
| Total Debt | 7.79 M | |||
| Debt To Equity | 3.00 % | |||
| Current Ratio | 5.62 X | |||
| Book Value Per Share | 8.92 X | |||
| Cash Flow From Operations | (140.46 M) | |||
| Earnings Per Share | 0.31 X | |||
| Target Price | 393.2 | |||
| Number Of Employees | 61 | |||
| Beta | 0.61 | |||
| Market Capitalization | 26.34 B | |||
| Total Asset | 897.73 M | |||
| Net Asset | 897.73 M |
About BioArctic Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze BioArctic AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BioArctic using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BioArctic AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in BioArctic Stock
BioArctic financial ratios help investors to determine whether BioArctic Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BioArctic with respect to the benefits of owning BioArctic security.